Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
- Name
- Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker
- Accession Number
- DBCAT003515
- Description
Not Available
- Drugs
Drug Drug Description Ivabradine A HCN channel blocker used to reduce the risk of hospitalization for worsening heart failure in adult patients and for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy in pediatric patients. - Drugs & Drug Targets
Drug Target Type Ivabradine Cytochrome P450 3A4 enzyme Ivabradine Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 target